News & Updates | Alliance Healthcare UK

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Zamadol SR 50 mg prolonged-release hard capsules

Mylan UK Healthcare Ltd has informed us that the GTIN barcode applied on the above batches is incorrect. The GTIN number that should have been allocated for these batches of capsules is 05060035240173, however, 05060035241477 was applied in error which scans the batches as Zamadol Melt Tablet 50mg. All other information on the carton and label, including the EAN barcode is correct for the above batches of Zamadol SR 50 mg prolonged-release hard capsules.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
2427003	ZAMADOL SR CAP 50MG	MYLAN UK HEALTHCARE	8L221D 9B225A

For more information or medical information enquiries please contact Mylan UK Healthcare Ltd. Medical Information Department on +44(0) 1707 853000 or via email on Info.uk@mylan.co.uk

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Esmya Tab 5mg

Gedeon Richter (UK) Ltd is recalling all unexpired stock of the above products from patients, pharmacies and wholesalers following a new case of liver failure requiring liver transplant in a patient taking the medicine. To protect patients while a safety review is conducted, the European Medicines Agency's safety committee, Pharmacovigilance Risk Assessment Committee, (PRAC) has recommended that women stop taking 5mg ulipristal acetate (Esmya and generic medicines) for uterine fibroids.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3707510	ESMYA TAB 5MG	GEDEON RICHTER LTD	ALL STOCK

For stock control and/or medical information enquiries please contact Gedeon Richter (UK) Ltd on +44 (0) 1279 406 759

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall on Beconase Aqueous Nasal Spray GSK

Update: Returns for credit must be received by Friday 20th March 2020

Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of the below batch. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.' Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
383307	BECONASE AQ NASAL 50MCG	GLAXOSMITHKLINE UK LTD	K84X

For stock control enquiries please contact 0800 221441.

For medical information enquiries please contact ukmedinfo@gsk.com , via the Live Chat facility or on 0800 221 441 (option 2).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall on Beconase Aqueous Nasal Spray GSK

Update: Returns for credit must be received by Friday 20th March 2020

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
383307	BECONASE AQ NASAL 50MCG	GLAXOSMITHKLINE UK LTD	K84X

For stock control enquiries please contact 0800 221441.

For medical information enquiries please contact ukmedinfo@gsk.com , via the Live Chat facility or on 0800 221 441 (option 2).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Emerade Auto-Injector 150 Bausch & Lomb UK

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3849221	EMERADE 150 AUTO-INJECTOR	BAUSCH & LOMB UK	ALL STOCK

For stock enquiries please contact Bausch & Lomb Customer Services, Tel: 020 8781 2991

For medical information enquiries please contact the Pharmacovigilance and Medical Information Officer, Tel: 0208 781 5523, Email: Pharmacovigilance.UK@bausch.com

Email: Pharma_CS@bausch.com - please note, only in-date pens that are returned by patients, will be refunded, (i.e. expiry date of March 2020 onwards).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Tetrabenazine Tab 25mg AOP Orphan Pharmaceuticals AG

AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of the below batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay, obtained during routine stability testing.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Livery	Affected Batch
6838841	TETRABENAZINE TAB 25MG	AOP Orphan Pharmaceuticals AG	T1704UK
3580073	TETRABENAZINE TAB 25MG	AOP Orphan Pharmaceuticals AG	T1704UK

For more information or medical information queries, please contact medinfo@aoporphan.com.

For stock control queries, please contact orderservice@aoporphan.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Alliance Healtchare do not stock this batch therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Oxylan Prolonged-Release Tablets

G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety relevant text changes.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Livery	Affected Batch
6359814	OXYCODONE PR TAB 10MG	Healthcare Pharma Ltd	9F115A 9F116A
6359822	OXYCODONE PR TAB 20MG	Healthcare Pharma Ltd	9J114A
6359830	OXYCODONE PR TAB 40MG	Healthcare Pharma Ltd	9F119A
6359798	OXYCODONE PR TAB 80MG	Healthcare Pharma Ltd	9F120A
8113458	OXYCODONE SR TAB 10MG	Healthcare Pharma Ltd	9F115A 9F116A
8456030	OXYCODONE SR TAB 20MG	Healthcare Pharma Ltd	9J114A
8456014	OXYCODONE SR TAB 40MG	Healthcare Pharma Ltd	9F119A
8455917	OXYCODONE SR TAB 80MG	Healthcare Pharma Ltd	9F120A
3726122	OXYCODONE PR TAB 10MG	Healthcare Pharma Ltd	9F115A 9F116A
3726130	OXYCODONE PR TAB 20MG	Healthcare Pharma Ltd	9J114A
3726148	OXYCODONE PR TAB 40MG	Healthcare Pharma Ltd	9F119A
3726155	OXYCODONE PR TAB 80MG	Healthcare Pharma Ltd	9F120A
1196971	OXYCODONE PR TAB 80MG/td>	Healthcare Pharma Ltd	9F120A

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

For more information or medical information queries, please contact: GL Pharma GmbH on +43 3136 82577 or office@gl-pharma.at.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Recall on Glutafin Gf Pizza Bases

DR SCHAR is recalling the below batch because the Incorrect product is in the correct outer case.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3341112	GLUTAFIN GF PIZZA BASES	DR SCHAR	220620C

For all enquiries, please contact DR SCHAR Customer services on 0800 161 5838

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Memantine 10mg Film-Coated Tablets

Crescent Pharma Ltd has informed us of a discrepancy on the product packaging for the below batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error. The incorrect end flap states that the quantity of tablets within the pack is 30, however this is incorrect and should state 28 as per all other sides of the pack, (see Annex 1). The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
8130825	MEMANTINE HYD TAB 10MG	CRESCENT PHARMA LTD	10819 20819 11119
1208925	MEMANTINE TABS 10MG	CRESCENT PHARMA LTD	10819 20819 11119
1182922	MEMANTINE HCL TAB 10MG	CRESCENT PHARMA LTD	10819 20819 11119
1148048	MEMANTINE TAB 10MG	CRESCENT PHARMA LTD	10819 20819 11119

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

For more information or medical information queries, please contact: Crescent Pharma Ltd. Medical Information Department on +00351 214643225, via email on tiago.barca@pharsolution.com or +44 (0) 1256 772740.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Gliclazide Tab 40mg

Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing..

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batches
1217223	GLICLAZIDE TAB 40MG ALM	ACCORD-UK LTD (NORTHSTAR LIVERY)	GU50
1217231	GLICLAZIDE TAB 40MG TEV	ACCORD-UK LTD (NORTHSTAR LIVERY)	GU50
1207596	GLICLAZIDE TAB 40MG ACT	ACCORD-UK LTD (NORTHSTAR LIVERY)	GU50
8427023	OTCD GLICLAZIDE TAB 40MG	ACCORD-UK LTD (NORTHSTAR LIVERY)	GU50
8107104	GLICLAZIDE TAB 40MG	ACCORD-UK LTD (NORTHSTAR LIVERY)	GU50

ALLIANCE DO NOT STOCK. Please return all affected stock to your original supplier for credit.

For stock control enquiries please contact Accord Customer Services Team on 0800 373573.

For medical information enquiries please contact Accord Medical Information Department on 01271 385257.

If you have any questions, then please contact your local Service Centre Customer Services team.